Form 4: MapLight General Counsel Sells Shares for Tax Obligations

MapLight Therapeutics' General Counsel, Kristopher Hanson, disposed of 26,007 shares of common stock to cover tax withholding obligations related to RSU settlement.

Summary

• Kristopher Hanson, General Counsel of MapLight Therapeutics, Inc. (MPLT), reported a transaction involving the company's common stock.
• On January 27, 2026, Hanson disposed of 26,007 shares of Voting Common Stock.
• The shares were disposed of at a price of $17.98 per share.
• This transaction was identified as a tax withholding event (Code 'F'), meaning the shares were withheld by the Issuer to satisfy tax obligations related to the settlement of restricted stock unit awards.
• Following this transaction, Kristopher Hanson beneficially owns 183,852 shares of Voting Common Stock directly.
• The securities retained by Hanson remain subject to a 180-day lock-up agreement from the initial public offering's final prospectus date of October 26, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. The transaction is a routine tax-related disposition of shares by an insider, which typically does not reflect a change in the company's fundamental outlook or the insider's confidence.

Future Outlook

The filing does not contain specific forward-looking statements or guidance regarding the company's future performance or strategic direction. It primarily reports a past insider transaction.

Industry Context

StockSavvy.ai notes that tax-related sales by insiders, such as those to cover withholding obligations upon the vesting or settlement of restricted stock units, are a common and routine occurrence. These transactions are generally not indicative of an insider's sentiment towards the company's future prospects but rather a standard administrative event.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine tax-related transaction by an insider, not a discretionary sale indicating a change in sentiment. The number of shares is small relative to the total outstanding.

Next Steps

• The remaining securities held by Kristopher Hanson are subject to a lock-up agreement, restricting their sale or transfer for 180 days following the IPO's final prospectus date of October 26, 2025, meaning the lock-up will expire around April 24, 2026.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by an insider to cover tax obligations associated with RSU settlement. Such transactions do not typically provide new fundamental information about the company's performance or future prospects, nor do they signal a change in the insider's long-term view. Therefore, a 'hold' recommendation is appropriate as this event does not warrant a change in investment strategy based solely on this filing.

Keywords

MapLight Therapeutics, MPLT, Form 4, insider transaction, stock sale, tax withholding, restricted stock units, Kristopher Hanson, corporate governance